Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Summit Therapeutics (SMMT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
25 analysts
Options Flow (P/C)
0.32
More calls — Bullish
Avg Consensus PT
$32
+199.8%
Highest Price Target
$44
+318.7%
Lowest Price Target
$8
-21.0%
Short Interest
27.0%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Bernstein | Jeffrey Walch— | -21.0% | $12 → $8 | Downgrade | Market Perform→Underperform |
| Nov 16, 2026 | Citigroup | Yigal Nochomovitz— | +299.6% | $43 → $42 | Maintained | Buy |